China Hemodialysis and Peritoneal Dialysis Market Report and Forecast 2025-2034

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Hemodialysis and Peritoneal Dialysis: Introduction

Peritoneal dialysis and hemodialysis are alternatives for dialysis for patients with end-stage renal disease in whom preventive kidney transplantation is not possible. Hemodialysis is performed through a machine that filters the body’s blood and toxins through a dialyzer (also known as an artificial kidney). In peritoneal dialysis, the tiny blood vessels inside the abdominal lining filter blood with the help of a dialysis solution.

China Hemodialysis and Peritoneal Dialysis Market Analysis

The China hemodialysis and peritoneal dialysis market value is being driven by factors like growing ESRD patients, increasing prevalence of diabetes and high blood pressure, and the growing number of dialysis facilities across the country. The growing preference for dialysis treatments among consumers owing to the risk associated with kidney transplants is expected to aid the industry growth over the forecast period.

With the help of increasing mergers and partnerships between native and international companies, the region is witnessing a notable emphasis on integrating new solutions to offer better patient alternatives. Japan based Terumo Corporation and WEGO Terumo (Weihai) Medical Products CO., Ltd., received the National Medical Products Administration (NMPA) approval to market and manufacture the first neutralized peritoneal dialysis solution in the country. Such partnerships play a critical role in fueling the hemodialysis and peritoneal dialysis market growth.

The growing convergence of digital and artificial intelligence enabled devices is also expected to boost market growth. With government and private initiatives, there is high emphasis on educating the healthcare professionals to properly use modern technology.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

China Hemodialysis and Peritoneal Dialysis Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

China Hemodialysis and Peritoneal Dialysis Market Overview

The China hemodialysis and peritoneal dialysis market demand is being driven by the rising health concerns among consumers, the growing disposable incomes, and the rapidly emerging economies within the region. With the advent of minimally invasive tools, the patient volume has been relatively higher owing to convenient procedures and faster recovery period.

With a significant rise in healthcare investments, there has been a notable increase in the number of dialysis centers in China. The segment of hemodialysis will hold the largest share in the market, primarily due to greater accessibility of HD centers, an increasing number of public dialysis centers, increased knowledge and understanding of the management of HD, reimbursement coverage, and socio-demographic factors. In addition, the growing focus of key players for expanding their business in the country will boost the hemodialysis and peritoneal dialysis market share globally as well.

China Hemodialysis and Peritoneal Dialysis Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Asahi Kasei Medical Co., ltd.
• Shandong Weigao Group Medical Polymer Company Limited
• Shenzhen Landwind Industry Co., Ltd.
• Baxter International Inc.
• B.Braun Melsungen AG
• Davita Healthcare Partners Inc.
• Fresenius Medical Care AG & Co. KGaA
• Nikkiso Co., Ltd.
• Nipro Corporation
• NxStage Medical, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.